Thanks to a minimally invasive treatment, quality of life is preserved, and returning to daily activities is faster.
HIFU treatment : advantages for the patient
Minimally invasive treatment : maintains quality of life and allows a quick return to normal life
Treatment of localized prostate cancer with High-Intensity Focused Ultrasound (HIFU) is considered a minimally invasive procedure, meaning that no incision is made and therefore no scar is left. The side effects commonly associated with conventional treatments for localized prostate cancer are limited, thanks to the preservation of surrounding organs such as the urinary sphincter (responsible for urinary continence) and the erectile nerves (responsible for erections).(1) The HIFU treatment probe is inserted into the rectum to reach the prostate easily, as it is located just behind the rectal wall.
For more information
HIFU treatment procedure
Treatment is administered in a single session, under general or locoregional anesthetic, as the patient and anesthetist deem most appropriate. The patient is positioned lying down on their right side (in a fetal position).
HIFU treatment results
In 2024, a published French trial(1) including more than 3300 patients enrolled at 46 sites proved the non-inferiority of HIFU treatment compared with standard surgery, in terms of oncological results at 30 months.
INS-491I – 2022/04/28 – 394 804 447 RCS Lyon
Focal One® est fabriqué par EDAP TMS. Ce dispositif médical est un produit de santé réglementé qui porte, au titre de cette réglementation, le marquage CE. Focal One est destiné à la destruction par ultrasons focalisés de haute intensité par voie rectale d’un adénocarcinome localisé de la prostate. Il est impératif de vous référer à votre urologue.